About Acmex
Acmex Bio-Technology (Chongqing) Co., Ltd., established in August 2021, is located in the earth (international) life science park,Chongqing, with a plant area of 6,000 square meters. Acmex has a strong scientific research base with experienced research team, jointly undertaking many national high-tech projects with many domestic universities and research institutions. Our world-class R&D platform for monoclonal antibodies, recombinant antigens and in vitro diagnostic reagents provides a reliable guarantee for the smooth implementation of scientific research and product development. We are committed to becoming a leading enterprise in the whole industrial chain of IVD industry.
Quality Certificate
The company follows the EN ISO:13485:2016, YY/T02870-2017idt ISO 13485:2016 "Medical Device Quality Management System for Regulatory Requirements", IVDR (In Vitro Diagnostic Medical Device), CMDR ( Canada Medical Device Regulation SOR/98-282) and GB/T 19001-2015 "Quality Management System Requirements", to achieve the quality policy and quality objectives of the enterprise, effectively implement and continuously improve the quality management system, and provide customers with satisfactory products and services.
Manufacturing and Sales
Based on the standardized quality system, we have set up multiple product R&D and manufacturing bases in China and Canada, and our products cover most of the mainstream clinical assays. Every year, we bring hundreds of millions of high-quality diagnostic reagents to market through our global marketing network, providing product solutions and technical support services to customers in more than 100 countries and regions worldwide.